Perception and Coverage of Conventional Vaccination among University Students from Rouen (Normandy), France in 2021.
confidency
university students
utility
vaccination coverage
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
07 Jun 2022
07 Jun 2022
Historique:
received:
13
04
2022
revised:
02
06
2022
accepted:
03
06
2022
entrez:
24
6
2022
pubmed:
25
6
2022
medline:
25
6
2022
Statut:
epublish
Résumé
The aim of this study was to assess vaccination perception and the prevalence of the overall vaccination coverage (VC) and associated factors among university students. An online study was conducted among students of a university in Rouen (Normandy), France, in January 2021, with questions about the VC and perception of the vaccines. The convenience sample included 3089 students (response rate of 10.3%), with a mean age of 20.3 (SD = 1.9). The overall VC was 27.8% (39.2% for the healthcare students (HCS) and 21.3% for the non-HCS; p < 0.0001). Confidence (efficacy and security) was lower than the conviction of usefulness. The characteristics associated with VC were having the intention to be vaccinated against COVID-19, high perceptions of usefulness for their own health, having confidence in the vaccines’ efficacy and security, and a high estimated level of knowledge about vaccination. Education about the general interest and mechanism of action of vaccines could improve the perception of vaccines. Then, it is relevant to improve vaccination literacy and confidence in university students, who, as future adults and parents, will vaccinate themselves and their children; as well as healthcare students who are future healthcare workers and, therefore, will vaccinate and counsel their patients.
Identifiants
pubmed: 35746516
pii: vaccines10060908
doi: 10.3390/vaccines10060908
pmc: PMC9228726
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
PLoS One. 2019 Oct 31;14(10):e0224330
pubmed: 31671115
Am J Health Promot. 2021 Jun;35(5):708-719
pubmed: 33530696
Hum Vaccin Immunother. 2022 Dec 31;18(1):1-3
pubmed: 33625960
Vaccines (Basel). 2020 Dec 30;9(1):
pubmed: 33396832
PLoS One. 2018 Dec 7;13(12):e0208601
pubmed: 30532274
J Health Commun. 2011 Mar;16(3):227-9
pubmed: 21391044
Hum Vaccin Immunother. 2021 May 4;17(5):1304-1312
pubmed: 33118868
Health Educ Q. 1988 Summer;15(2):175-83
pubmed: 3378902
Vaccine. 2019 Sep 10;37(38):5681-5687
pubmed: 31421931
Eur J Epidemiol. 2020 Aug;35(8):781-783
pubmed: 32761440
Int J Ment Health Nurs. 2022 Aug;31(4):857-867
pubmed: 35289065
Vaccine. 2021 Aug 23;39(36):5129-5137
pubmed: 34334252
Vaccine. 2020 Jan 22;38(4):794-799
pubmed: 31708179
Vaccines (Basel). 2021 Jun 10;9(6):
pubmed: 34200835
BMC Med Educ. 2020 Dec 14;20(1):508
pubmed: 33317501
JMIR Serious Games. 2020 May 18;8(2):e16983
pubmed: 32348271
Vaccines (Basel). 2021 Jun 15;9(6):
pubmed: 34203847
Cochrane Database Syst Rev. 2020 Jan 17;1:CD011895
pubmed: 31978259
Vaccines (Basel). 2019 May 12;7(2):
pubmed: 31083632
J Community Health. 2016 Oct;41(5):1078-89
pubmed: 27147417
Vaccine. 2020 Oct 7;38(43):6794-6799
pubmed: 32896467
Vaccine. 2021 Jun 8;39(25):3435-3444
pubmed: 33992435
Vaccine. 2019 May 31;37(25):3310-3316
pubmed: 31064676
BMC Public Health. 2021 Apr 26;21(1):804
pubmed: 33902501
J Health Commun. 2020 Oct 2;25(10):799-807
pubmed: 33719881
J Am Coll Health. 2020 Aug-Sep;68(6):593-602
pubmed: 30908142
Vaccine. 2021 Apr 8;39(15):2060-2067
pubmed: 33741191
Int J Environ Res Public Health. 2021 Mar 23;18(6):
pubmed: 33806763
PLoS One. 2022 Jan 6;17(1):e0262192
pubmed: 34990482
Vaccine. 2021 Mar 5;39(10):1508-1515
pubmed: 33573865
J Med Ethics. 2021 Oct;47(10):709-711
pubmed: 33504627
Vaccine. 2020 Jul 14;38(33):5131-5138
pubmed: 32409135
Vaccine. 2018 Jun 18;36(26):3861-3867
pubmed: 29605516
Hum Vaccin Immunother. 2022 Dec 31;18(1):2036555
pubmed: 35240936
Hum Vaccin Immunother. 2019;15(11):2552-2553
pubmed: 31013184
J Am Coll Health. 2022 May 27;:1-6
pubmed: 35622961